NEUROCRINE BIOSCIENCES INC financial statements, including revenue, expenses, profit, and loss

The total revenue of NB3 for the last quarter is 477.57 M EUR, and it's 2.31% higher compared to the previous quarter. The net income of Q1 24 is 40.22 M EUR.